US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Nov. 18 for "Chimeric antigen receptors targeting CD-19" (Maryland Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,359, issued on Nov. 18, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Chimeric antigen receptors targeting CD-19" was invented by James N. Kochenderfer (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to a chimeric antigen receptor (CAR) directed against CD19, which comprises an amino acid sequence of any one of SEQ ID NO: 1-SEQ ID NO: 13. The invention also provides T-cells expressing the CAR and methods for destroying malignant B-cells."

The patent was filed on March 16, 2022, under Application No. 17/696,249.

*For fu...